NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Pharmabiz12h
NanoViricides announces its antiviral drug, NV-387 can fight bird flu pandemic; H5N1 virus will not be able to escape even as it changes in the field
Shelton, Connecticut Thursday, February 13, 2025, 16:00 Hrs [IST] ...
Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) Claims NV-387 Ready To Combat Bird Flu
NanoViricides, Inc. (NYSE American: NNVC) announced its broad-spectrum antiviral NV-387 as a potential solution for combating H5N1 bird flu, stating ...
NanoViricides Engages CRO for Phase II Clinical Trial
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
ScienceAfrica on MSN22h
Project ECHO: Virtual Learning Transforming Africa’s Emergency Response
By Gift BritonWith disproportionate disease burden, limited resources, and healthcare workers stretched thin, a virtual learning platform is changing how health professionals in Africa respond to ...
Miami Herald17d
NanoViricides Engages CRO for Phase II Clinical Trial
MPox disease, caused by the human Mpox virus (hMPXV) has been causing a regional ... activity against an orthopoxvirus in an animal model that is considered an important model to establish ...